Switch to:
PDL BioPharma, Inc. (NAS:PDLI)
Additional Paid-In Capital
$-233.2 Mil (As of Dec. 2013)

PDL BioPharma, Inc.'s quarterly additional paid-in capital increased from Jun. 2013 ($-233.7 Mil) to Sep. 2013 ($-233.5 Mil) and increased from Sep. 2013 ($-233.5 Mil) to Dec. 2013 ($-233.2 Mil).

PDL BioPharma, Inc.'s annual additional paid-in capital declined from Dec. 2011 ($-161.8 Mil) to Dec. 2012 ($-234.1 Mil) but then increased from Dec. 2012 ($-234.1 Mil) to Dec. 2013 ($-233.2 Mil).


Definition

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

PDL BioPharma, Inc. Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
AdditionalPaidInCapital 686.3969.11,037.81,098.3169.2-83.9-87.4-161.8-234.1-233.2

PDL BioPharma, Inc. Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
AdditionalPaidInCapital -161.9-161.8-234.8-234.6-234.4-234.1-233.9-233.7-233.5-233.2
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide